02-Nov-2026 20:59:40
SUNPHARMAGeneral news
SUNPHARMA : CLARIFIES ASSAM PLANT NEWS REPORT, SAYS NO NEW EVENT
• Company says the news report on halting eye-care drug production at its Assam plant relates to developments from August 2026 • Matter was assessed at the relevant time and was not considered to warrant disclosure under Regulation 30 • Company announced Q2 and H1 FY27 results (quarter and half year ended 30 September 2026) on 30 October 2026 • Company is not in a position to attribute the share price movement to the news report or any particular factor • Confirms no undisclosed material event or information requiring Regulation 30 disclosure Impact: Neutral (exchange clarification only; no new regulatory action or financial figure disclosed, company points to its 30 October results)
Sun Pharmaceutical Industries Limited
Open attachment